GI-MAP™

GI-MAP™

Unparalleled DNA-Based Stool Testing

The Gastrointestinal Microbial Assay Plus (GI-MAP™) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample with state of the art, quantitative polymerase chain reaction (qPCR or real-time PCR) technology.

PCR vs. Conventional Stool Testing Using Culture Plates

The GI-MAP is much more sensitive than a conventional stool test. PCR technology amplifies DNA of the microorganisms that are present. The microorganism does not have to be alive for it to be detected. For example, a parasite could be dead or in a dormant phase and it will still be detected in the stool test. PCR does not rely on the microorganisms that are alive and able to grow on a culture plate outside the human body.

Ultimately, certain bacteria, parasites, etc. can be spotted on the GI-MAP that may have been missed on a conventional stool test. This is a perfect example where a test’s specific technology is important to receiving the correct diagnoses.

The GI-MAP™ takes a snapshot of your gut microbiome to identify what normal species are present and in what amounts. The test quantitatively assesses the gut microbiome with attention to bacterial, parasitic and viral pathogens that can cause disease, disrupt the normal microbial balance and contribute to chronic GI illness. It also evaluates markers for pathogens, inflammation, digestion capacity and toxicity.

It’s important to note that not all individuals with positive findings for pathogens will present with symptoms. Many factors, including the health of the individual, the transient nature of some pathogens, and the presence and expression of virulence factors all contribute to an individual’s symptoms.

The GI-MAP is incorporated with the nutritional programming to treat pathogens and imbalances in the gut microbiota and restore gut health in those experiencing GI symptoms.


For individuals with symptoms of:

  • Suspected H. pylori Infection

  • Fungal or Yeast Infections

  • Bacterial & Parasitic Infections

  • Intestinal Permeability

  • Viral Pathogens

  • Chronic and Acute Gastroenteritis

  • Inflammatory Bowel Disease (IBD)

  • Irritable Bowel Syndrome (IBS)

  • Autoimmune Disease

  • Small Intestinal Bacterial Overgrowth (SIBO)


Evaluation of:

  • H. pylori with Virulence Factors

  • Fungi/Yeast

  • Digestion

  • Immune Response

  • Inflammation

  • Antibiotic Resistance Genes

  • Bacterial Pathogens

  • Viral Pathogens

  • Parasitic Pathogens

  • Parasitic Protozoa

  • Parasitic Worms

  • Normal Bacterial Flora

  • Opportunistic Bacteria


Test Details

  • Collection: stool sample

  • Test Results: 7-10 business days

  • Follow Up Testing: as necessary